Previous close | 11.08 |
Open | 11.09 |
Bid | 9.50 x 800 |
Ask | 12.09 x 800 |
Day's range | 11.09 - 12.01 |
52-week range | 7.40 - 13.97 |
Volume | |
Avg. volume | 362,015 |
Market cap | 624.398M |
Beta (5Y monthly) | 0.95 |
PE ratio (TTM) | 65.99 |
EPS (TTM) | 0.18 |
Earnings date | 27 Feb 2023 - 03 Mar 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 25.00 |
For many investors, the main point of stock picking is to generate higher returns than the overall market. But its...
Cara Therapeutics ( NASDAQ:CARA ) Third Quarter 2022 Results Key Financial Results Revenue: US$10.8m (down 47% from 3Q...
Cara (CARA) delivered earnings and revenue surprises of -2.38% and 28.91%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?